Tiffany Carlaw

CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics.

C. Ross, Tiffany Carlaw, Linhui Zhang, 2020, Human gene therapy.

Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG.

C. Ross, Tiffany Carlaw, Linhui Zhang, 2022, The CRISPR journal.

A Luciferase Reporter Mouse Model to Optimize In Vivo Gene Editing Validated by Lipid Nanoparticle-Mediated Delivery of Adenine Base Editors.

J. Kulkarni, G. Basha, Tiffany Carlaw, 2023, Molecular therapy : the journal of the American Society of Gene Therapy.